作者
Julia S. Wong,Hajime Uno,Angela C. Tramontano,Lauren Fisher,Catherine V. Pellegrini,Gregory A. Abel,Harold J. Burstein,Yoon S. Chun,Tari A. King,Deborah Schrag,Eric P. Winer,Jennifer R. Bellon,Matthew D. Cheney,Patricia H. Hardenbergh,Alice Y. Ho,Kathleen C. Horst,Janice N. Kim,Kara-Lynne Leonard,Meena S. Moran,Catherine C. Park,Abram Recht,Daniel E. Soto,R. Shiloh,Susan Stinson,Kurt M. Snyder,Alphonse G. Taghian,Laura Warren,Jean L. Wright,Rinaa S. Punglia
摘要
Postmastectomy radiation therapy (PMRT) improves local-regional disease control and patient survival. Hypofractionation (HF) regimens have comparable efficacy and complication rates with improved quality of life compared with conventional fractionation (CF) schedules. However, the use of HF after mastectomy in patients undergoing breast reconstruction has not been prospectively examined.